Page 71 - Read Online
P. 71
Griffiths et al. Neuroimmunol Neuroinflammation 2020;7:51-67 I http://dx.doi.org/10.20517/2347-8659.2019.21 Page 67
67. Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, et al. Effect of high-dose simvastatin on brain atrophy and disability in
secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 2014;383:2213-21.
68. Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, et al. Increased cortical grey matter lesion detection in multiple
sclerosis with 7 T MRI: a post-mortem verification study. Brain 2016;139:1472-81.
69. Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, et al. Multiple sclerosis deep grey matter: the relation between
demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386-95.
70. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, et al. Demyelination versus remyelination in progressive
multiple sclerosis. Brain 2010;133:2983-98.
